Effect of operation-synchronizing transfusion of apoptotic spleen cells from donor rats on acute rejection of recipient rats after liver transplantation

Table 1 ALT and T bili in recipients in each group 1 wk after liver transplantation.

Groups	n	ALT (IU/L)		T bili (mmol/L)
		mean±SE		95% Confidence interval	95% Confidence interval
Blank	9	201.1	60.3	154.8-247.5	1.2-4.8
Control	10	259	138.1	161.1-358.7	7.6-27.2
Dex	9	293.9	94.9	220.9-366.8	15.4-43.2
SpC	9	433.8	123.2	339.1-528.5a	33.7-69.7
Dex-SpC	8	717.0	178.5	567.8-866.2b	69.1-111.4

^aP<0.05 vs Control, Dex;

^bP<0.001 vs Control, Dex, SpC. ALT: Alanine transaminase; T bili: Total bilirubin; Blank: The group without liver transplantation; Control: The group only with liver transplantation; Dex: The group treated with dexamethasone; SpC: The group treated with spleen cells; Dex-SpC: The group treated with dexamethasone and spleen cells.

Table 2 Scores of pathology classification for acute rejection in each group.

Group	n	Rejection active index
		1	4	5	6	7	8	9
Blank	2	2
Control	10		9	1
Dex	10			1	9
SpC	10				5	4	1
Dex-SpC	9						2	7

Abbreviations as in Table 1.

Table 3 Survival period after liver transplantation in each group.

Groups	n	Survival period (d)	Mean (d)
Control	10	11, 18, 40, 47, >70 (×2), >71 (×2), >96, >97	69.8
Dex	10	9, 15, 18, 26, 29, >38, >68,, >69, >87, >99	56.2
SpC	10	10, 13, 14, 15, 29, 40, 47, >37 (×2), >38	29.9
	1	0.5 (death from surgical reasons)
Dex-SpC	+		15.3
	9		10, 11, 12, 13, 15, 16, 17, >18, >22

Abbreviations as in Table 1.